Make Your Voice Heard on Lupus Drug Development
The national lupus patient advocacy community is excited to announce that people with lupus will have the chance to be...
Stories & News
Novel Research Grants Push Discoveries
10 New Grants, 10 New Insights
The path to safe and effective treatments and ultimately a cure lies in bold,...
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...